Article Details
Retrieved on: 2018-03-20 06:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Amy Abernethy, chief medical officer and chief scientific officer for <b>Flatiron Health</b>, questioned how those organizations offering trials can ensure that all available patients are contributing to them. “How do we use the data that's already occurring as a byproduct of care in a smarter way?” she asked.</div>
Article found on:
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here